Page 1 of 1

#1

Posted: Mon Sep 01, 2025 8:25 pm
by RSS Post Bot
For people with macular telangiectasia type 2 (MacTel), an orphan retinal disorder that gradually destroys central vision, there have long been no approved treatment options. But now, a new study sponsored by Neurotech Pharmaceuticals and spearheaded by investigators at Scripps Research and the National Institutes of Health offers compelling evidence that vision loss can be slowed with a neuroprotective surgical implant.

Source: https://www.sciencedaily.com/releases/2 ... 022831.htm